|
1
|
Young RJ, Brown NJ, Reed MW, Hughes D and
Woll PJ: Angiosarcoma. Lancet Oncol. 11:983–991. 2010.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Wheelwright M, Spartz EJ, Skubitz K,
Yousaf H, Murugan P and Harmon JV: Primary angiosarcoma of the
spleen, a rare indication for splenectomy: A case report. Int J
Surg Case Rep. 82(105929)2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Guglielmelli P, Rotunno G, Pacilli A, Rumi
E, Rosti V, Delaini F, Maffioli M, Fanelli T, Pancrazzi A, Pieri L,
et al: Prognostic impact of bone marrow fibrosis in primary
myelofibrosis. A study of the AGIMM group on 490 patients. Am J
Hematol. 91:918–922. 2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Neuhauser TS, Derringer GA, Thompson LD,
Fanburg-Smith JC, Miettinen M, Saaristo A and Abbondanzo SL:
Splenic angiosarcoma: A clinicopathologic and immunophenotypic
study of 28 cases. Mod Pathol. 13:978–987. 2000.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Kania BE and Vasani S: A case report of
splenic rupture secondary to underlying angiosarcoma. Cureus.
12(e9439)2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Fury MG, Antonescu CR, Van Zee KJ, Brennan
MF and Maki RG: A 14-year retrospective review of angiosarcoma:
Clinical characteristics, prognostic factors, and treatment
outcomes with surgery and chemotherapy. Cancer J. 11:241–247.
2005.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Gorzelak-Pabis P, Zuszek-Frynas A and
Broncel M: Primary splenic angiosarcoma: A very rare and aggressive
neoplasm with a poor prognosis. Pol Arch Intern Med. 130:142–144.
2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Damouny M, Mansour S and Khuri S: Primary
Angiosarcoma of the Spleen: An aggressive neoplasm. World J Oncol.
13:337–342. 2022.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Xu B, Xie X, Zhou X, Zhai M and Yang W:
Spontaneous rupture of primary splenic angiosarcoma: A case report.
Oncol Lett. 10:3271–3273. 2015.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Khorzhevskii VA, Ermachenko DA, Gappoev SV
and Levkovich LG: Metastatic lesion of the bone marrow caused by
primary angiosarcoma of the spleen. Arkh Patol. 84:52–55.
2022.PubMed/NCBI View Article : Google Scholar : (In Russian).
|
|
11
|
Badiani R, Schaller G, Jain K, Swamy R and
Gupta S: Angiosarcoma of the spleen presenting as spontaneous
splenic rupture: A rare case report and review of the literature.
Int J Surg Case Rep. 4:765–767. 2013.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Koutelidakis IM, Tsiaousis PZ, Papaziogas
BT, Patsas AG, Atmatzidis SK and Atmatzidis KS: Spleen rupture due
to primary angiosarcoma: A case report. J Gastrointest Cancer.
38:74–77. 2007.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Ozcan B, Cevener M, Kargi AO, Dikici H,
Yıldız A, Özdoğan M and Gürkan A: Primary splenic angiosarcoma
diagnosed after splenectomy for spontaneous rupture. Turk J Surg.
34:68–70. 2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Levy ACJ, DeFilipp M, Blakely M, Asiry S,
Jormark S and Goodman A: Splenic angiosarcoma diagnosed on bone
marrow biopsy: Case report and literature review. Radiol Case Rep.
14:390–395. 2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Li R, Li M, Zhang LF, Liu XM, Hu TZ, Xia
XJ, Chi JS, Jiang XX and Xu CX: Clinical characteristics and
prognostic factors of primary splenic angiosarcoma: A retrospective
clinical analysis from China. Cell Physiol Biochem. 49:1959–1969.
2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Takahashi H, Hara T, Suzuki H, Hashimoto R
and Minami M: FDG-PET/CT demonstrates splenic angiosarcoma bone
marrow metastasis. Clin Nucl Med. 45:e20–e23. 2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Abdallah RA, Abdou AG, Asaad NY,
Al-Sharaky DR and Alhanafy AM: Primary epithelioid angiosarcoma of
spleen: A case report and review of literature. J Clin Diagn Res.
10:ED05–ED07. 2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Chen D, Tang M, Lv S, Wang H, Du W, Zhao
X, Lin L, Zhu Y, Wang G, Zhu H and Zhao K: Prognostic usefulness of
clinical features and pretreatment (18)F-FDG PET/CT metabolic
parameters in patients with angiosarcoma. Quant Imaging Med Surg.
12:2792–2804. 2022.PubMed/NCBI View Article : Google Scholar
|
|
19
|
An R, Ma JY, Ni XH and Wang CL:
Angiosarcoma of the breast with hypofibrinogenemia: A rare case
report and review of the literature. Front Oncol.
12(1047935)2022.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Mori S, Taki T, Murakami Y, Urata T,
Okumura M, Akanabe H, Ebata A, Imai S, Yokota K and Akiyama M: Low
plasma fibrinogen levels are associated with poor prognosis in
cutaneous angiosarcoma of the head and neck. Cancer Sci.
112:3924–3927. 2021.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Juin Hsien BL and Shelat VG: Spleen
angiosarcoma: A world review. Expert Rev Gastroenterol Hepatol.
15:1115–1141. 2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Smrke A, Hamm J, Karvat A, Simmons C and
Srikanthan A: A retrospective review of 145 patients with
angiosarcoma: Radiation therapy, extent of resection and
chemotherapy are important predictors of survival. Mol Clin Oncol.
13:179–185. 2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Zhao Q, Dong A, Wang Y, He T and Zuo C:
FDG PET/CT in primary splenic angiosarcoma with diffuse involvement
of the spleen. Clin Nucl Med. 42:815–817. 2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Yamamoto T, Umeda T and Nishioka K:
Immunohistological distribution of stem cell factor and kit
receptor in angiosarcoma. Acta Derm Venereol. 80:443–445.
2000.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Shantzer L, Berger K and Pu JJ: Primary
myelofibrosis and its targeted therapy. Ann Hematol. 96:531–535.
2017.PubMed/NCBI View Article : Google Scholar
|
